Cresco Labs Inc.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$300.1M
Cash Runway
1.2 mo
Lead Asset
cresco ti implant concept
Next Catalyst
—
Tracking 4 pipeline candidates for Cresco Labs Inc. · Updated within the last hour.
Go deeper on Cresco Labs Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on CRLBF — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
1.2 months
D/E 2.78
No tracked pipeline phase
4 candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of December 31, 2025
Cash
$94.3M
Quarterly Burn
$352.6M
Revenue
$655.8M
Free Cash Flow
$37.8M
Total Liabilities
$944.8M
Shareholders Equity
$340.4M
Current Ratio
2.59
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$249K
| Holder | Shares | Value |
|---|---|---|
| first national trust co | 113,837 | $99K |
| albert d mason inc | 88,035 | $77K |
| ancora advisors llc | 60,169 | $53K |
| curio wealth, llc | 20,161 | $18K |
| strategic investment solutions, inc. /il | 1,408 | $1K |
| hurley capital, llc | 1,014 | $882 |
| thompson investment management, inc. | 725 | $631 |
| hantz financial services, inc. | 9,020 | $8 |
Frequently asked questions
Who is the CEO of Cresco Labs Inc.?
Mr. Charles Bachtell is the chief executive officer of Cresco Labs Inc. (CRLBF).
Where is Cresco Labs Inc. headquartered?
Cresco Labs Inc. (CRLBF) is headquartered in Chicago, IL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Cresco Labs Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.